5%利多卡因贴剂用于单侧腹股沟疝修补术患者术后疼痛管理的疗效与安全性:一项前瞻性、双盲、随机、对照临床试验的研究方案
这是一项单中心、前瞻性、双盲、随机、对照临床试验的研究方案,拟将单侧腹股沟疝患者随机分为利多卡因贴剂组或安慰剂贴剂组,在全身麻醉下开放疝修补术后将贴剂贴于手术伤口附近。主要结局为日间手术单元出院时用视觉模拟量表(VAS)测量的疼痛强度,次要结局为术后24小时和1周的VAS评分。该试验可能为5%利多卡因贴剂用于单侧腹股沟疝修补术后急性疼痛管理提供证据,并展示该贴剂用于出院后疼痛管理的疗效和安全性。
要点
- 单侧腹股沟疝患者随机接受5%利多卡因贴剂或安慰剂贴剂,贴于开放疝修补术后手术伤口附近。
- 主要结局为日间手术单元出院时VAS疼痛强度,次要结局为术后24小时和1周VAS评分。
- 将收集术中阿片类药物用量、恢复时间、术后30分钟疼痛强度及人口学特征并分析。
核心结论
- 该试验可能为5%利多卡因贴剂用于单侧腹股沟疝修补术后急性疼痛管理提供证据,并展示该贴剂用于出院后疼痛管理的疗效和安全性。
研究设计与样本
- 单中心、前瞻性、双盲、随机、对照临床试验。
- 单侧腹股沟疝参与者随机分配至利多卡因贴剂组或安慰剂贴剂组,在全身麻醉下开放疝修补术后将利多卡因贴剂或安慰剂贴剂贴于手术伤口附近。
- 参与者于术后第1天至门诊随访,并于术后1周随访。
主要发现
- 主要结局为日间手术单元出院时用视觉模拟量表(VAS)测量的疼痛强度。
- 次要结局为术后24小时和1周的VAS评分。
- 将收集并分析术中阿片类药物用量、恢复时间、术后30分钟疼痛强度及年龄、性别、体重、身高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute postoperative pain is a common complication of inguinal hernia repair. Pain management using local application of anesthetic agents over the skin surrounding the surgical incision may reduce the requirement for other pain medications. Targeted topical analgesics such as 5% lidocaine patches have been known to improve acute and chronic pain. However, the clinical effect of lidocaine patches on postoperative pain after inguinal hernia repair has not been studied, especially in patients undergoing surgery at day surgery units. METHODS/DESIGN: This is a single-center, prospective, double-blind, randomized, controlled clinical trial. Participants with unilateral inguinal hernia will be randomized to the lidocaine patch group or the placebo patch group. Based on the randomized allocation sequence, either lidocaine patches or placebo patches will be attached near each participant's surgical wound after open hernia repair under general anesthesia. Participants will be asked to follow up at our outpatient clinic on the first postoperative day and at 1 week after surgery. The primary outcome is pain intensity, which will be measured using the visual analog scale (VAS) at the time of discharge from the day surgery unit. The secondary outcomes are VAS score at 24 h and 1 week after surgery. We will collect and analyze the participants' clinical data (amount of intraoperative opioid use, time to recovery, and pain intensity at 30 min after surgery) and demographic characteristics (age, sex, body weight, and height). DISCUSSION: This trial may not only provide evidence on the efficacy of a 5% lidocaine patch for acute postoperative pain management after unilateral inguinal hernia repair, but also demonstrate the efficacy and safety of the patch for post-discharge pain management. TRIAL REGISTRATION: ClinicalTrials.gov NCT04754451. Registered on February 10, 2021.
引用
- Ahn HM, Oh HK, Kim DW, et al. Efficacy and safety of 5% lidocaine patches for postoperative pain management in patients undergoing unilateral inguinal hernia repair: study protocol for a prospective, double-blind, randomized, controlled clinical trial. Trials. 2022. PMID: 36089597. doi:10.1186/s13063-022-06700-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。